Mwj. Boehme et al., CLINICAL RELEVANCE OF ELEVATED SERUM THROMBOMODULIN AND SOLUBLE E-SELECTIN IN PATIENTS WITH WEGENERS GRANULOMATOSIS AND OTHER SYSTEMIC VASCULITIDES, The American journal of medicine, 101(4), 1996, pp. 387-394
PURPOSE: Vascular injury plays an important pathophysiological role in
vasculitis. Soluble serum thrombomodulin (sTM), a promising marker of
endothelial cell injury, is released into the circulating blood follo
wing cell damage and was therefore investigated as a parameter of dise
ase activity in patients with Wegener's granulomatosis (WG) and variou
s other vasculitides. PATIENTS AND METHODS: One hundred and ninety-sev
en sera of 102 patients with histologically proven WG of different dis
ease activity and 41 sera of patients with other vasculitides at their
active stage were investigated (12 Takayasu arteritis [TA], 7 giant c
ell arteritis [GCA], 10 polyarteritis nodosa [PAN], 12 Behcet's diseas
e [BD]). The sera were examined for the levels of sTM and sE-selectin
(CD62E) by enzyme-linked immunosorbent assay (ELISA) and for the prese
nce of classical anti-neutrophil cytoplasmic antibodies (cANCA) by ind
irect immunofluorescence (IIF). The disease activity was evaluated acc
ording to the clinical symptoms and organ involvement. RESULTS: A sign
ificant increase of sTM levels compared with control values (26 +/- 2
ng/ml) was found in active WG, TA, GCA, PAN, and BD: limited active WG
: 63 +/- ng/ml; generalized active WG: 119 +/- 15 ng/ml; limited WG, p
artial remission: 60 +/- 5 ng/ml; generalized WG, partial remission: 7
5 +/- 7 ng/ml; active TA: 36 +/-; active GCA: 36 +/- 4 ng/ml, active P
AN: 33 +/- 2 ng/ml, active BD: 40 +/- 4 ng/ml. Limited and generalized
WG in complete remission did not have elevated levels of sTM. sTM val
ues closely reflected relapses and therapy-induced remissions of WG. E
levated cANCA titers were correlated as well with the disease activity
in WG but more weakly than sTM levels. In contrast, sE-selectin value
s were not significantly correlated with the disease activity and the
course of disease. CONCLUSIONS: sTM is a promising serological marker
of disease activity and progression in active limited and generalized
WG and other vasculitides reflecting the degree of endothelial cell da
mage. sTM might prove to be a clinically useful marker for therapeutic
considerations.